Study Details
Testing the Drug RE104 to Treat Postpartum Depression
(IRB#: IRB_00176449)
Postpartum depression can occur after a woman has childbirth. This study will test a drug called RE104 to treat women with this condition. The study wants to see if the drug will help people with the condition and is safe. Participants in the study will be randomly chosen to be treated with a low or high dose of RE104. The drug will be given one time under the skin of the upper arm. Being in the study requires a total of about 10 to 11 study visits in person at the study clinic with some of the visits over the phone. Participation lasts about 53 days. Medical tests will be done during the study to track the health of participants.
- Female Only
- Over 18 years old
- Volunteers with special conditions
- In Person
- Unpaid
Who can participate?
Gender: Female Only
Age: Over 18 years old
Volunteers: Volunteers with special conditions
Location: In Person
Inclusion Criteria
- Females ages 18 to 45 years old
- Symptoms of depression anytime during the second trimester of the pregnancy through 4 weeks following delivery
- Use specific birth control during study participation
- Able to attend in person at the study clinic
Exclusion Criteria
- Breastfeeding
- Pregnant
- Serious risk of suicide
- Active or history of other specific mental health disorders
- Current alcohol or substance abuse
Will I be paid for my time?
No
IRB#: IRB_00176449
PI: Benjamin Lewis
Department: PSYCHIATRY
Approval Date: 2024-07-10 06:00:00
Study Categories: Mental Health and Well-being Studies
Specialties: Psychiatry